Literature DB >> 17004632

Part-time occlusion therapy for anisometropic amblyopia detected in children eight years of age and older.

Young Rok Lee1, Ju Youn Lee.   

Abstract

PURPOSE: To determine the outcome of part-time occlusion therapy in children with anisometropic amblyopia detected after they were 8 years of age.
METHODS: We analyzed 29 eyes with anisometropic amblyopia in children 8 years of age and older. The mean age was 8.79 +/- 0.98 (range 8-12) years old. The subjects whose best-corrected visual acuity (BCVA) did not improve by two lines or better within 2 weeks of wearing glasses full-time were prescribed occlusion therapy for 6 hours a day outside of school hours, along with the instruction to wear glasses full-time. Subjects who complied with occlusion for more than 3 hours a day were considered to comply well.
RESULTS: The major component of the anisometropia was hyperopia in 51.7% of the subjects, and hyperopia plus astigmatism was found in 24.1%. The mean pretreatment BCVA score was 0.51 0.23 (LogMAR). Compliance was 89.66%. The mean posttreatment BCVA was 0.03 +/- 0.01 (LogMAR), and the success rate, based on a posttreatment BCVA of 0.1 (LogMAR) and better, was 96.43%. It took an average of 4.79 +/- 3.35 months to reach the desired posttreatment BCVA. The mean posttreatment stereopsis was 79.78 +/- 37.61 seconds of arc. The recurrence rate was 8%. The visual improvement was related to the degree of compliance (p = 0.000). The time taken to reach the posttreatment BCVA was shorter in subjects with a better pretreatment BCVA (p = 0.019), but it did not relate to the compliance (p = 0.366).
CONCLUSIONS: The most common component of anisometropia detected after 8 years of age was hyperopia. The part-time occlusion therapy, which had been carried out after school hours, was successful in most cases.

Entities:  

Mesh:

Year:  2006        PMID: 17004632      PMCID: PMC2908842          DOI: 10.3341/kjo.2006.20.3.171

Source DB:  PubMed          Journal:  Korean J Ophthalmol        ISSN: 1011-8942


  16 in total

1.  Occlusion for amblyopia: a comprehensive survey of outcome.

Authors:  F Hiscox; N Strong; J R Thompson; C Minshull; G Woodruff
Journal:  Eye (Lond)       Date:  1992       Impact factor: 3.775

2.  Efficacy and stability of amblyopia therapy.

Authors:  R P Rutstein; P S Fuhr
Journal:  Optom Vis Sci       Date:  1992-10       Impact factor: 1.973

3.  Classification of amblyopia.

Authors:  G K Von Noorden
Journal:  Am J Ophthalmol       Date:  1967-02       Impact factor: 5.258

4.  Risk of amblyopia recurrence after cessation of treatment.

Authors:  Jonathan M Holmes; Roy W Beck; Raymond T Kraker; William F Astle; Eileen E Birch; Stephen R Cole; Susan A Cotter; Sean Donahue; Donald F Everett; Richard W Hertle; Ronald V Keech; Evelyn Paysse; Graham F Quinn; Michael X Repka; Mitchell M Scheiman
Journal:  J AAPOS       Date:  2004-10       Impact factor: 1.220

5.  Successful occlusion therapy for amblyopia in 11- to 15-year-old children.

Authors:  Kanwar Mohan; Vandana Saroha; Ashok Sharma
Journal:  J Pediatr Ophthalmol Strabismus       Date:  2004 Mar-Apr       Impact factor: 1.402

6.  The sensitive period for strabismic amblyopia in humans.

Authors:  M Epelbaum; C Milleret; P Buisseret; J L Dufier
Journal:  Ophthalmology       Date:  1993-03       Impact factor: 12.079

7.  A randomized trial of patching regimens for treatment of moderate amblyopia in children.

Authors:  Michael X Repka; Roy W Beck; Jonathan M Holmes; Eileen E Birch; Danielle L Chandler; Susan A Cotter; Richard W Hertle; Raymond T Kraker; Pamela S Moke; Graham E Quinn; Mitchell M Scheiman
Journal:  Arch Ophthalmol       Date:  2003-05

8.  Efficacy of amblyopia therapy initiated after 9 years of age.

Authors:  K H Park; J-M Hwang; J K Ahn
Journal:  Eye (Lond)       Date:  2004-06       Impact factor: 3.775

9.  Compliance and results of treatment for amblyopia in children more than 8 years old.

Authors:  M Oliver; R Neumann; Y Chaimovitch; N Gotesman; M Shimshoni
Journal:  Am J Ophthalmol       Date:  1986-09-15       Impact factor: 5.258

10.  Long-term follow-up of L-dopa treatment in children with amblyopia.

Authors:  Lawrence E Leguire; Kelly L Komaromy; Theresa M Nairus; Gary L Rogers
Journal:  J Pediatr Ophthalmol Strabismus       Date:  2002 Nov-Dec       Impact factor: 1.402

View more
  3 in total

1.  Is There a Critical Period for Amblyopia Therapy? Results of a Study on Older Anisometropic Amblyopes.

Authors:  Taskin Khan
Journal:  J Clin Diagn Res       Date:  2015-08-01

2.  Part-time occlusion therapy for amblyopia in older children.

Authors:  Inderpreet Singh; Nishant Sachdev; Gagandeep S Brar; Sushmita Kaushik
Journal:  Indian J Ophthalmol       Date:  2008 Nov-Dec       Impact factor: 1.848

Review 3.  Current Management of Childhood Amblyopia.

Authors:  Shin Hae Park
Journal:  Korean J Ophthalmol       Date:  2019-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.